Starling Oncology STLN
NASDAQ STLN
$6.51 -0.13 (-1.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

Starling Oncology (STLN) EBITDA Margin (2021 - 2026)

Updated

Starling Oncology's EBITDA Margin was -1.72% in Q2 2026, up 6.13 percentage points from -7.85% a year earlier and up 1.60 percentage points from the prior quarter.

Analysis

Starling Oncology (STLN) EBITDA Margin (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Starling Oncology's EBITDA Margin was -3.28% through Jun 30, 2026, up 6.15 percentage points year-over-year; for FY2025, it was -5.80%, up 7.89 percentage points from FY2024.

  • EBITDA Margin has now increased for three consecutive years, though with a five-year change of -3.12 percentage points (FY2020 to FY2025).
  • In earlier years, EBITDA Margin was -13.68% in FY2024 (+8.26 pp), -21.94% in FY2023 (+8.77 pp), -30.71% in FY2022 (-9.77 pp) and -20.94% in FY2021 (-18.27 pp).
  • The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q2 2021.
  • Compared with a year earlier, EBITDA Margin has increased for 13 straight quarters, with an average year-over-year change of +6.25 percentage points over the last eight quarters.
  • The best year-over-year quarter for EBITDA Margin over five years was Q4 2022 (a gain of 42.86 percentage points); the worst was Q1 2022 (a drop of 29.69 percentage points).
  • Per Business Quant data, STLN's EBITDA Margin in the three quarters before Q2 2026 was -3.32% (Q1 2026), -3.72% (Q4 2025) and -4.64% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 HCA Healthcare 94.29 Bn 93.74 Bn - 19.96%
2 Natera 59.14 Bn 54.82 Bn 485.19 Mn -7.25%
3 Quest Diagnostics 26.23 Bn 24.66 Bn 1.03 Bn 19.88%
4 Labcorp Holdings 25.04 Bn 22.81 Bn 1.11 Bn 16.90%
5 Guardant Health 23.69 Bn 19.76 Bn 219.03 Mn -35.69%
6 Tenet Healthcare 20.77 Bn 11.92 Bn - 30.49%
7 Tempus AI 14.91 Bn 11.94 Bn 246.50 Mn -
8 Encompass Health 12.24 Bn 12.70 Bn - 24.09%
9 Davita 11.39 Bn 10.15 Bn 1.16 Bn 21.01%
10 Starling Oncology 667.11 Mn 534.52 Mn 27.17 Mn -1.72%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.72%
Mar 31, 2026 -3.32%
Dec 31, 2025 -3.72%
Sep 30, 2025 -4.64%
Jun 30, 2025 -7.85%
Mar 31, 2025 -7.78%
Dec 31, 2024 -10.19%
Sep 30, 2024 -12.29%
Jun 30, 2024 -15.06%
Mar 31, 2024 -17.41%
Dec 31, 2023 -15.98%
Sep 30, 2023 -14.90%
Jun 30, 2023 -16.96%
Mar 31, 2023 -41.47%
Dec 31, 2022 -33.44%
Sep 30, 2022 -29.18%
Jun 30, 2022 -28.24%
Mar 31, 2022 -31.70%
Dec 31, 2021 -76.31%
Sep 30, 2021 -2.50%
API Access

Starling Oncology EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=STLN&period=max&api_key=YOUR_API_KEY